AFC-HD AMS Life Science Co., Ltd.
2927.T · JPX
8/31/2025 | 8/31/2024 | 8/31/2023 | 8/31/2022 | |
|---|---|---|---|---|
| Market Cap | ¥12,055,127 | ¥11,717,377 | ¥11,178,706 | ¥10,819,997 |
| - Cash | ¥11,199,883 | ¥12,172,000 | ¥11,182,021 | ¥10,377,778 |
| + Debt | ¥24,142,084 | ¥22,891,658 | ¥19,537,816 | ¥17,134,955 |
| Enterprise Value | ¥24,997,328 | ¥22,437,035 | ¥19,534,501 | ¥17,577,174 |
| Revenue | ¥32,655,022 | ¥30,185,451 | ¥25,579,009 | ¥22,997,127 |
| % Growth | 8.2% | 18% | 11.2% | – |
| Gross Profit | ¥10,970,052 | ¥10,491,451 | ¥9,322,878 | ¥8,578,963 |
| % Margin | 33.6% | 34.8% | 36.4% | 37.3% |
| EBITDA | ¥3,799,472 | ¥3,097,634 | ¥2,587,520 | ¥2,299,651 |
| % Margin | 11.6% | 10.3% | 10.1% | 10% |
| Net Income | ¥1,448,545 | ¥1,252,067 | ¥1,102,564 | ¥735,353 |
| % Margin | 4.4% | 4.1% | 4.3% | 3.2% |
| EPS Diluted | 102.97 | 88.96 | 78.46 | 52.08 |
| % Growth | 15.7% | 13.4% | 50.7% | – |
| Operating Cash Flow | ¥1,786,827 | ¥1,540,093 | ¥865,280 | ¥1,492,417 |
| Capital Expenditures | -¥3,538,771 | -¥3,406,797 | -¥1,939,681 | -¥957,971 |
| Free Cash Flow | -¥1,751,944 | -¥1,866,704 | -¥1,074,401 | ¥534,446 |